Abstract
This photo essay shows the transient therapeutic effect of pars plana vitrectomy (PPV) in a patient affected by primary intraocular lymphoma (PIOL). PPV is crucial for the diagnosis of PIOL, but it may also play a role in the therapeutic approach.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Primary intraocular lymphomas (PIOL) are aggressive tumors that may also involve the central nervous system (CNS). PIOL are usually extranodal, non-Hodgkin, diffuse, large B-cell type lymphomas that belong to the family of primary CNS lymphomas [1]. T-cell PIOL have been also rarely reported. Clinical presentations typically include vitreous haze and a yellowish tissue infiltrating the subretinal space, often mimicking posterior and intermediate uveitis.
The pictures show presence (Fig. 1), disappearance after diagnostic pars plana vitrectomy (PPV) (Fig. 2), and recurrence 20 days after surgery (Fig. 3) of a case of PIOL occurred in the left eye of a 70-year-old woman. Although first PPV did not allow a diagnosis, the removal of vitreous with resident inflammatory cells and mediators caused reduction of the secondary inflammatory process with regression of macular edema. Because vitritis and macular edema recurred, a second diagnostic PPV including vitreoretinal biopsy was performed. Immunohistological analysis of specimens (Fig. 4) confirmed diagnosis of PIOL, and a therapeutic regimen with intravitreal (IVT) methotrexate and rituximab was instituted.
Comment
PIOL is typically considered a Masquerade Syndrome. Diagnostic PPV is often crucial to differentiate PIOL from intermediate and posterior uveitis. Venkatesh et al. reported prolonged remission after PPV in a case of PIOL refractory to IVT chemotherapy [2]. In our case, PPV provided only a transient therapeutic effect probably due to removal of the reactive T-cell infiltrate in B-cell lymphomas [3]. In conclusion PPV is crucial in the diagnosis of PIOL, but it may also play an important role in the therapeutic approach.
References
Touitou V, LeHoang P, Bodaghi B (2015) Primary CNS lymphoma. Curr Opin Ophthalmol 6(6):526–533
Davis JL, Ruiz P Jr, Shah M, Mandelcorn ED (2012) Evaluation of the reactive T-cell infiltrate in uveitis and intraocular lymphoma with flow cytometry of vitreous fluid (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc 110:117–129
Venkatesh P, Gogia V, Khanduja S, Gupta S, Kumar L, Garg S (2015) Therapeutic vitrectomy for vitreal recurrence of intraocular lymphoma resistant to intravitreal methotrexate post systemic chemotherapy. Cancer Res Ther. 11(3):668
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Iaccheri, B., Fiore, T., Cerquaglia, A. et al. Transient therapeutic effect of vitrectomy in primary intraocular lymphoma. Int Ophthalmol 37, 1333–1335 (2017). https://doi.org/10.1007/s10792-016-0405-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-016-0405-2